Plains GP PAGP Stalls at 2351 Consolidation Phase 20260513 Royalty Pharma Plc RPRX Exploring the Undervaluation Potential in Biotech Royalty Investing TrumpXi Meeting Could Reshape Indias Role as Chinas Strategic Counterweight